Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Science Translational Medicine|July 1, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosisAlexandros Rampotas, Zoë C Wong, Isaac Gannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2021
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaClaire Roddie, Juliana Dias, Maeve A O'Reilly, et al.
Leukemia|November 20, 2024
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT studyGuillermo Ortí, Christophe Peczynski, William Boreland, et al.
Blood|September 6, 2018
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signatureMichael A Chapman, Jonathan Sive, John Ambrose, et al.
Blood Advances|March 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphomaAndrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Journal of Hepatology|August 14, 2025
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinomaTim Meyer, Richard S Finn, Mitesh Borad, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
The New England Journal of Medicine|November 27, 2024
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic LeukemiaClaire Roddie, Karamjeet S Sandhu, Eleni Tholouli, et al.
Blood Cancer Journal|April 15, 2024
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access schemeMacarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, et al.
Blood|June 10, 2023
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendationsKai Rejeski, Marion Subklewe, Mahmoud Aljurf, et al.
Pageof 9